Abstract
Multiple myeloma (MM) is the second most frequent hematological malignancy in the western world, and is characterized by the infiltration and clonal proliferation of antibody-secreting plasma cells in the bone marrow. Therapeutic options for MM have rapidly evolved over the past years. Despite the high initial efficacy of these new
... read more